D'Orazio & Associates’s Teladoc Health TDOC Stock Holding History

D'Orazio & Associates’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-177	Closed	-$35K	–	416
2020 Q4	$35K	Buy	+177	New	+$36K	0.01%	175

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

D'Orazio & Associates's TDOC Position: Q1 2021 in Review

D'Orazio & Associates sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 177 shares — an estimated $35K sold.

D'Orazio & Associates first reported a position in TDOC in Q4 2020 and held it in 1 quarter. The position peaked at $35K in Q4 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

D'Orazio & Associates reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
D'Orazio & Associates sold 177 Teladoc Health shares in Q1 2021, an estimated $35K.
D'Orazio & Associates first reported a position in Teladoc Health in Q4 2020 and held it in 1 quarter.
D'Orazio & Associates's Teladoc Health position peaked at $35K in Q4 2020.
889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on D'Orazio & Associates's 13F filing for Q1 2021, filed 5 May 2021.